SORRENTO THERAPEUTICS INC (SRNE) Earnings History & Surprises

NASDAQ:SRNEUS83587F2020

Current stock price

0.3073 USD
-0.08 (-20.26%)
At close:
0.2801 USD
-0.03 (-8.85%)
After Hours:

SRNE Earnings overview

Past quarterly earnings results for SORRENTO THERAPEUTICS INC (SRNE), including EPS and revenue actuals, analyst estimates, and surprise percentages. This page focuses on historical performance (not forecasts).

Earnings Snapshot

Next Earnings Date

Upcoming
Release Date
N/A
Period
Q4 / 2022
EPS Estimate
-$0.23
Revenue Estimate
16.905M

Last Reported

Most Recent
Release Date
Nov 8, 2022
Period
Q3 / 2022
EPS Reported
-$0.20
EPS Surprise
23.11%
Revenue Surprise
25.48%

Beat Rate

Last 8 Quarters
0%
EPS and Revenue beats vs estimates

Quarterly Earnings Historical Results

EPS & Revenue History (in USD): Actual vs estimated values, surprises, q2q growth and acceleration numbers quarterly history.

QuarterEPSEPS EstEPS SurpriseEPS Q2QRevenueRevenue EstRevenue SurpriseRevenue Q2Q
Q3 2022 -0.20 -0.26 23.11% 50.00% 17.4M 13.867M 25.48% 44.25%
Q2 2022 -0.54 -0.26 -111.76% 5.26% 11.461M 19.128M -40.08% -58.72%
Q1 2022 -0.16 - -1,732.00% 18.385M 25.52M -27.96% 28.57%
Q4 2021 -0.47 -0.30 -56.20% -74.07% 13.076M 15.429M -15.25% 13.70%
Q3 2021 -0.40 -0.23 -70.50% -21.21% 12.062M 10.383M 16.17% 2.22%
Q2 2021 -0.57 -0.20 -179.41% -58.33% 27.766M 10.329M 168.82% 208.51%
Q1 2021 0.01 0.38 -97.40% 104.35% 14.3M 17.598M -18.74% 85.71%
Q4 2020 -0.27 2.77 -109.75% - 11.5M 1.032B -98.89% -
Q3 2020 -0.33 -0.21 -57.82% - 11.8M 10.519M 12.18% -
Q2 2020 -0.36 -0.22 -60.43% - 9M 8.16M 10.29% -
Q1 2020 -0.23 -0.20 -12.75% - 7.7M 10.2M -24.51% -

Notes

  • EPS and Revenue values are non-GAAP when available, otherwise GAAP.
  • Surprise % is (Actual - Estimate) / |Estimate|. Green indicates positive surprise, red negative.
  • Q2Q % is quarter-over-quarter growth. Green indicates growth, red indicates decline.
  • Green right border indicates acceleration for sales or earnings growth. Acceleration is the case when the current Q2Q is above the previous Q2Q.

Earnings Q2Q Performance Trends

EPS Historical Q2Q growth and Acceleration

SRNE EPS Q2Q GrowthSRNE EPS Q2Q GrowthEPS Q2Q Growth Q1/21 Q2/21 Q3/21 Q4/21 Q1/22 Q2/22 Q3/22 Q4/22 0 -500 -1K -1.5K

Revenue Historical Q2Q growth and Acceleration

SRNE Revenue Q2Q GrowthSRNE Revenue Q2Q GrowthRevenue Q2Q Growth Q1/21 Q2/21 Q3/21 Q4/21 Q1/22 Q2/22 Q3/22 Q4/22 0 50 -50 100 150 200

Surprise distribution (Last 4 Quarters)

EPS beat statistics

EPS beat (4)
1
Average EPS beat (4)
-48.29%
Max EPS beat (4)
23.11%
Min EPS beat (4)
-111.77%

Revenue beat statistics

Revenue beat (4)
1
Average Revenue beat (4)
-14.45%
Max Revenue beat (4)
25.48%
Min Revenue beat (4)
-40.08%

Analysis

In the last 4 quarters, SRNE has beaten EPS estimates in 1 out of 4 releases
SRNE has beaten revenue estimates in 1 out of the last 4 releases
In the last 4 quarters, SRNE reported -48.3% below the EPS estimates on average.
In the last 4 quarters, SRNE reported -14.5% below the revenue estimates on average.

SORRENTO THERAPEUTICS INC / SRNE Earnings FAQ

When did SORRENTO THERAPEUTICS INC (SRNE) report earnings last quarter?

SORRENTO THERAPEUTICS INC (SRNE) last reported earnings on 11/8/2022.

Can you provide information on whether SORRENTO THERAPEUTICS INC beat earnings estimates in the last quarter?

SORRENTO THERAPEUTICS INC (SRNE) beat EPS estimates and beat revenue estimates in the most recent quarter.

How often does SORRENTO THERAPEUTICS INC (SRNE) beat earnings estimates?

In the last 4 quarters, SORRENTO THERAPEUTICS INC (SRNE) has beaten EPS estimates in 1 out of 4 releases.